{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"3ac289c690fef8481c4bf722520862f708f5116ab982137bba89f36ad7b242a9","attributes":{"feedName":"fda","feedSource":"fda","title":"Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products","description":"Altaire is initiating the recall due to management concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility.","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/altaire-pharmaceuticals-inc-issues-voluntary-recall-multiple-ophthalmic-products","publicationDate":"2019-07-03T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers","professionals"],"categories":["drugs"],"contaminants":["other"],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"possible","token":"5d9e68e18b079e002a252029"}}}